Phase 3, randomized, double-blind, placebo-controlled study to investigate the effect of tirzepatide on reducing morbidity and mortality in adults with obesity
CLINICAL TRIAL WITH MEDICINES
Clinical trial information
- Promoter: LILLY, SA
- Phase: III
- Execution start: 14/11/2022
- End of execution: 30/09/2027
- IP: MIGUEL QUESADA CHARNECO